The Src Family Kinase Inhibitors PP2 and PP1 Block TGF-Beta1-Mediated Cellular Responses by Direct and Differential Inhibition of Type I and Type II TGF-Beta Receptors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|4|524-535

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.4, 2011-05, pp. : 524-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COMPLEX INTERPLAY AMONG APOPTOSIS FACTORS: RB, P53, E2F, TGF-beta, CELL CYCLE INHIBITORS AND THE BCL2 GENE FAMILY

By Chiarugi V.   Magnelli L.   Cinelli M.  

Pharmacological Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 257-261

Academic Press

Access to resources Recommend Favorite

TGF-beta Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2934-2947

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-Beta: a Master Switch in Tumor Immunity

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4126-4134

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-Beta Signaling Manipulation as Potential Therapy for IBD

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1400-1404

Bentham Science Publishers

Access to resources Recommend Favorite

Lerdelimumab: 6B1, Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, Anti-Transforming-Growth-Factor-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, CAT 152, Human Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology

By  

Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. : 106-108

Adis International

Access to resources Recommend Favorite